beta-lactams has been researched along with Renal Insufficiency in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, KC; Chu, LW; Hon, FK; Mok, MY; Shea, YF | 1 |
| Cohen Tervaert, JW; de Man, P; Geerlings, CJ; Rietveld, AP; Touw, DJ | 1 |
| Chou, YC; Lee, KH; Ng, YY; Ueng, YF; Wu, CW; Yang, WC | 1 |
| Cunha, BA; Gerson, S; Giuga, J | 1 |
| Abusada, NJ; Fica, AE | 1 |
| Churchwell, MD; Depestel, DD; Jakob, V; Kinzig, M; Mueller, BA; Patel, JH; Sörgel, F; Stevenson, JM; Vilay, AM | 1 |
| Colagiovanni, DB; Faqi, AS; Gill, S; Lanphear, C | 1 |
| Garg, S; Marrie, TJ; Tyrrell, GJ; Vanderkooi, OG | 1 |
| Amodio-Groton, M; Hoffman-Roberts, HL; Lamp, KC; Moise, PA; Rashid, M; Rastogi, A; Sakoulas, G; Schweitzer, S; Yoon, MJ | 1 |
| DiNubile, MJ; Majumdar, AK; Nix, DE | 1 |
| Deutsch, PJ; Fisher, A; Hesney, M; Majumdar, AK; Mistry, GC; Sica, D; Swan, S; Wagner, JA; Xi, L; Xu, Y | 1 |
| Burkhardt, O; Derendorf, H; Welte, T | 1 |
2 review(s) available for beta-lactams and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Renal Insufficiency | 2004 |
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections | 2007 |
1 trial(s) available for beta-lactams and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Area Under Curve; Aspartate Aminotransferases; beta-Lactams; Drug Administration Schedule; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Insufficiency; Time Factors | 2006 |
9 other study(ies) available for beta-lactams and Renal Insufficiency
| Article | Year |
|---|---|
Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Neurotoxicity Syndromes; Renal Insufficiency; Severity of Illness Index; Time Factors | 2013 |
A practical thrice weekly Ertapenem dosage regime for chronic hemodialysis patients?
Topics: beta-Lactams; Female; Humans; Male; Renal Dialysis; Renal Insufficiency | 2013 |
The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.
Topics: Aged; Anti-Bacterial Agents; Asian People; beta-Lactams; Central Nervous System Diseases; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Male; Renal Dialysis; Renal Insufficiency | 2015 |
Predictors of ertapenem therapeutic efficacy in the treatment of urinary tract infections (UTIs) in hospitalized adults: the importance of renal insufficiency and urinary pH.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult | 2016 |
Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Ertapenem; Female; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Seizures | 2008 |
Ertapenem clearance during modeled continuous renal replacement therapy.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Dialysis Solutions; Ertapenem; Hemofiltration; Membranes, Artificial; Metabolic Clearance Rate; Models, Biological; Renal Dialysis; Renal Insufficiency; Swine | 2008 |
Juvenile toxicity study of faropenem medoxomil in beagle puppies.
Topics: Aging; Animals; Anti-Bacterial Agents; beta-Lactams; Bone Development; Creatinine; Dogs; Dose-Response Relationship, Drug; Energy Intake; Female; Kidney; Male; Metabolic Clearance Rate; No-Observed-Adverse-Effect Level; Organ Size; Renal Insufficiency; Toxicity Tests, Chronic; Weight Gain | 2010 |
Factors predicting mortality in invasive pneumococcal disease in adults in Alberta.
Topics: Adolescent; Adult; Alberta; Anti-Bacterial Agents; beta-Lactams; Cognition Disorders; Comorbidity; Drug Therapy, Combination; Female; Humans; Lung; Macrolides; Male; Multivariate Analysis; Pneumococcal Infections; Renal Insufficiency; Respiratory Distress Syndrome; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Young Adult | 2011 |
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Creatine Kinase; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Registries; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2013 |